Search
SS1(dsFv)-PE38
go.drugbank.com/drugs/DB17579InvestigationalSS1(dsFv)-PE38 is a recombinant anti-mesothelin immunotoxin. … SS1(dsFv)-PE38 is under investigation in clinical trial NCT01051934 (A Phase I Trial of SS1 (Dsfv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-small Cell Lung Adenocarcinoma
Linopristin
go.drugbank.com/drugs/DB19296ExperimentalLinopristin is an antibiotic of the streptogramin B class. It is one part of the combination product NXL 103, along with [Virginiamycin M1].
Salacetamide
go.drugbank.com/drugs/DB20217InvestigationalSalacetamide is a small molecule drug. … Salacetamide is under investigation in clinical trial NCT00220285 (Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma).
Aftobetin
go.drugbank.com/drugs/DB20425InvestigationalAftobetin is a small molecule drug. … Aftobetin is under investigation in clinical trial NCT02928211 (Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations).
Irampanel
go.drugbank.com/drugs/DB21123InvestigationalIrampanel is a small molecule drug. … Irampanel is under investigation in clinical trial NCT02222961 (Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers).
Rintodestrant
go.drugbank.com/drugs/DB21472InvestigationalRintodestrant is a small molecule drug. … Rintodestrant is under investigation in clinical trial NCT03455270 (G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer).
Itruvone
go.drugbank.com/drugs/DB21543InvestigationalItruvone is a small molecule drug. Itruvone is under investigation in clinical trial NCT02322086 (A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10).
Taragarestrant
go.drugbank.com/drugs/DB21574InvestigationalTaragarestrant is a small molecule drug. … Taragarestrant is under investigation in clinical trial NCT06954961 (A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer).
Esatenolol
go.drugbank.com/drugs/DB13443ExperimentalEsatenolol is a beta blocker.
Categories: s-atenololSynonyms: S-atenolol, S-(-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide